Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?

Aucott JN, Rebman AW, Crowder LA, Kortte KB.

Qual Life Res. 2013 Feb;22(1):75-84.

2.

Development of a foundation for a case definition of post-treatment Lyme disease syndrome.

Aucott JN, Crowder LA, Kortte KB.

Int J Infect Dis. 2013 Jun;17(6):e443-9. doi: 10.1016/j.ijid.2013.01.008. Epub 2013 Feb 23.

3.

The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.

Rebman AW, Bechtold KT, Yang T, Mihm EA, Soloski MJ, Novak CB, Aucott JN.

Front Med (Lausanne). 2017 Dec 14;4:224. doi: 10.3389/fmed.2017.00224. eCollection 2017.

4.

Posttreatment Lyme disease syndrome.

Aucott JN.

Infect Dis Clin North Am. 2015 Jun;29(2):309-23. doi: 10.1016/j.idc.2015.02.012. Review.

PMID:
25999226
5.

Update of the Swiss guidelines on post-treatment Lyme disease syndrome.

Nemeth J, Bernasconi E, Heininger U, Abbas M, Nadal D, Strahm C, Erb S, Zimmerli S, Furrer H, Delaloye J, Kuntzer T, Altpeter E, Sturzenegger M, Weber R, For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology.

Swiss Med Wkly. 2016 Dec 5;146:w14353. doi: 10.4414/smw.2016.14353. eCollection 2016. Review.

6.

[Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].

Dumas R, Boyer L, Richieri R, Guedj E, Auquier P, Lançon C.

Encephale. 2014 Feb;40(1):74-80. doi: 10.1016/j.encep.2013.04.004. Epub 2013 Oct 1. French.

PMID:
24091070
7.

Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.

Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, Cooper D, Nadelman RB, Visintainer P, Schwartz I, Wormser GP.

Clin Infect Dis. 2015 Dec 15;61(12):1800-6. doi: 10.1093/cid/civ735. Epub 2015 Sep 18.

8.

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

Geebelen L, Lernout T, Kabamba-Mukadi B, Saegeman V, Sprong H, Van Gucht S, Beutels P, Speybroeck N, Tersago K.

Arch Public Health. 2017 Aug 7;75:42. doi: 10.1186/s13690-017-0202-z. eCollection 2017.

9.

CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Bechtold KT.

Clin Vaccine Immunol. 2016 Sep 6;23(9):757-66. doi: 10.1128/CVI.00071-16. Print 2016 Sep.

10.

Standardized Symptom Measurement of Individuals with Early Lyme Disease Over Time.

Bechtold KT, Rebman AW, Crowder LA, Johnson-Greene D, Aucott JN.

Arch Clin Neuropsychol. 2017 Mar 1;32(2):129-141. doi: 10.1093/arclin/acw098.

PMID:
28365751
11.

Correlates of perceived health-related quality of life in post-treatment Lyme encephalopathy.

Chandra AM, Keilp JG, Fallon BA.

Psychosomatics. 2013 Nov-Dec;54(6):552-9. doi: 10.1016/j.psym.2013.04.003. Epub 2013 Jul 9.

12.

Health care costs, utilization and patterns of care following Lyme disease.

Adrion ER, Aucott J, Lemke KW, Weiner JP.

PLoS One. 2015 Feb 4;10(2):e0116767. doi: 10.1371/journal.pone.0116767. eCollection 2015.

13.

Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals.

Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W.

Am J Med. 1996 Oct;101(4):364-70.

PMID:
8873506
14.

High disease impact of myotonic dystrophy type 2 on physical and mental functioning.

Tieleman AA, Jenks KM, Kalkman JS, Borm G, van Engelen BG.

J Neurol. 2011 Oct;258(10):1820-6. doi: 10.1007/s00415-011-6027-8. Epub 2011 Apr 3.

15.

Evaluation of Prospectively Followed Adult Patients with Erythema Migrans Using the Beck Depression Inventory Second Edition.

Wormser GP, Park K, Madison C, Rozenberg J, McKenna D, Scavarda C, Karmen C, Dornbush R, Visintainer P.

Am J Med. 2018 Dec 16. pii: S0002-9343(18)31169-0. doi: 10.1016/j.amjmed.2018.11.039. [Epub ahead of print]

PMID:
30562495
16.

Sleep quality in well-defined Lyme disease: a clinical cohort study in Maryland.

Weinstein ER, Rebman AW, Aucott JN, Johnson-Greene D, Bechtold KT.

Sleep. 2018 May 1;41(5). doi: 10.1093/sleep/zsy035.

PMID:
29452400
17.

Aerobic exercise improves quality of life, psychological well-being and systemic inflammation in subjects with Alzheimer's disease.

Abd El-Kader SM, Al-Jiffri OH.

Afr Health Sci. 2016 Dec;16(4):1045-1055. doi: 10.4314/ahs.v16i4.22.

18.

Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients: A Randomized Clinical Trial.

Freedland KE, Carney RM, Rich MW, Steinmeyer BC, Rubin EH.

JAMA Intern Med. 2015 Nov;175(11):1773-82. doi: 10.1001/jamainternmed.2015.5220.

19.

Clinical and neurocognitive features of the post Lyme syndrome.

Bujak DI, Weinstein A, Dornbush RL.

J Rheumatol. 1996 Aug;23(8):1392-7.

PMID:
8856619
20.

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.

Berende A, ter Hofstede HJ, Donders AR, van Middendorp H, Kessels RP, Adang EM, Vos FJ, Evers AW, Kullberg BJ.

BMC Infect Dis. 2014 Oct 16;14:543. doi: 10.1186/s12879-014-0543-y.

Supplemental Content

Support Center